Amylyx Pharmaceuticals Inc's market cap is currently ―. The company's EPS TTM is $0.704; its P/E ratio is 2.81; Amylyx Pharmaceuticals Inc is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 108.45M	$ 102.69M	$ 98.22M	$ 71.43M	$ 21.89M
Gross Profit	$ 99.09M	$ 97.47M	$ 92.64M	$ 66.14M	$ 19.06M
EBIT	-	$ 22.41M	$ 24.01M	$ 1.40M	$ -45.28M
EBITDA	-	-	$ 22.30M	$ -1.30M	$ -46.96M
Net Income Common Stockholders	$ 4.73M	$ 20.91M	$ 22.07M	$ 1.60M	$ -42.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 371.36M	$ 355.05M	$ 357.28M	$ 345.67M	$ 346.94M
Total Assets	$ 517.45M	$ 466.58M	$ 453.59M	$ 407.96M	$ 391.45M
Total Debt	$ 4.24M	$ 4.77M	$ 5.29M	$ 5.79M	$ 6.28M
Net Debt	$ -367.13M	$ -350.28M	$ -351.99M	$ -339.89M	$ -340.67M
Total Liabilities	$ 84.02M	$ 48.18M	$ 67.22M	$ 55.31M	$ 50.85M
Stockholders Equity	$ 433.43M	$ 418.40M	$ 386.37M	$ 352.65M	$ 340.61M
Cash Flow	-
Free Cash Flow	-	-	$ 8.33M	$ -5.32M	$ -50.32M
Operating Cash Flow	$ 13.55M	$ -5.17M	$ 8.61M	$ -5.07M	$ -49.70M
Investing Cash Flow	$ 20.93M	$ -108.09M	$ 123.22M	$ 55.99M	$ -228.18M
Financing Cash Flow	$ 230.00K	$ 889.00K	$ 1.38M	$ 1.04M	$ 232.16M

Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History

Income Statement >

Amylyx Pharmaceuticals Inc Debt to Assets

Balance Sheet >

Amylyx Pharmaceuticals Inc Cash Flow

Cash Flow >

Amylyx Pharmaceuticals Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing